BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16302159)

  • 1. D-dimer testing in pregnancy.
    Eichinger S
    Semin Vasc Med; 2005 Nov; 5(4):375-8. PubMed ID: 16302159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-dimer testing in pregnancy.
    Eichinger S
    Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):327-9. PubMed ID: 15692237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
    Bombeli T; Raddatz-Mueller P; Fehr J
    Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden.
    Eichinger S; Weltermann A; Philipp K; Hafner E; Kaider A; Kittl EM; Brenner B; Mannhalter C; Lechner K; Kyrle PA
    Thromb Haemost; 1999 Oct; 82(4):1232-6. PubMed ID: 10544904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism in obstetrics and gynecology.
    Krivak TC; Zorn KK
    Obstet Gynecol; 2007 Mar; 109(3):761-77. PubMed ID: 17329532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of prophylactic heparin treatment on enhanced thrombin generation in pregnancy.
    Bremme K; Lind H; Blombäck M
    Obstet Gynecol; 1993 Jan; 81(1):78-83. PubMed ID: 8416465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pre- and postpartum hemostatic characteristics in pregnancy-related hypertension and pre-eclampsia in comparison with normotensive pregnancies].
    Hofmann M; Casper F; Prellwitz W; Brockerhoff P
    Z Geburtshilfe Neonatol; 1996; 200(3):104-8. PubMed ID: 8963881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-dimers as a screening test for venous thromboembolism in pregnancy: is it of any use?
    Damodaram M; Kaladindi M; Luckit J; Yoong W
    J Obstet Gynaecol; 2009 Feb; 29(2):101-3. PubMed ID: 19274539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in the evaluation of D-dimer and fibrinogen levels in pregnant women.
    Réger B; Péterfalvi A; Litter I; Pótó L; Mózes R; Tóth O; Kovács GL; Losonczy H
    Thromb Res; 2013 Apr; 131(4):e183-7. PubMed ID: 23481480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and management of venous thromboembolism in pregnancy.
    James AH
    Am J Med; 2007 Oct; 120(10 Suppl 2):S26-34. PubMed ID: 17916457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrin monomer complex in normal pregnant women: a potential thrombotic marker in pregnancy.
    Onishi H; Kaniyu K; Iwashita M; Tanaka A; Watanabe T
    Ann Clin Biochem; 2007 Sep; 44(Pt 5):449-54. PubMed ID: 17761030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypercoagulability during pregnancy: evidences for a thrombophilic state].
    Maiello M; Torella M; Caserta L; Caserta R; Sessa M; Tagliaferri A; Bernacchi M; Napolitano M; Nappo C; De Lucia D; Panariello S
    Minerva Ginecol; 2006 Oct; 58(5):417-22. PubMed ID: 17006429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of thrombosis in pregnancy: role of low-molecular-weight heparin.
    Kher A; Bauersachs R; Nielsen JD
    Thromb Haemost; 2007 Apr; 97(4):505-13. PubMed ID: 17393011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of an optimal dose of low-molecular-weight heparin for thromboprophylaxis in pregnant women at risk of thrombosis using coagulation activation markers.
    Bombeli T; Raddatz Mueller P; Fehr J
    Haemostasis; 2001; 31(2):90-8. PubMed ID: 11684864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-dimer levels, constitutional thrombophilia, and venous thrombosis prediction: clinical aspects and implications.
    Samama MM; Horellou MH; Elalamy I; Mathieux V; Ombandza-Moussa E; Conard J
    Semin Vasc Med; 2005 Nov; 5(4):371-4. PubMed ID: 16302158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy and deep vein thrombosis.
    Bates SM; Ginsberg JS
    Semin Vasc Med; 2001; 1(1):97-104. PubMed ID: 15199519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased activation of blood coagulation in pregnant women with the Factor V Leiden mutation.
    Kjellberg U; van Rooijen M; Bremme K; Hellgren M
    Thromb Res; 2014 Oct; 134(4):837-45. PubMed ID: 25135795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in D-dimer levels during pregnancy and the postpartum period: results of two studies].
    Boehlen F; Epiney M; Boulvain M; Irion O; de Moerloose P
    Rev Med Suisse; 2005 Jan; 1(4):296-8. PubMed ID: 15771359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial.
    Abou-Nassar K; Kovacs MJ; Kahn SR; Wells P; Doucette S; Ramsay T; Clement AM; Khurana R; Mackinnon K; Blostein M; Solymoss S; Kingdom J; Sermer M; Rey E; Rodger M;
    Thromb Haemost; 2007 Jul; 98(1):163-71. PubMed ID: 17598009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reference intervals of D-dimer during the pregnancy and puerperium period on the STA-R evolution coagulation analyzer.
    Wang M; Lu S; Li S; Shen F
    Clin Chim Acta; 2013 Oct; 425():176-80. PubMed ID: 23954836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.